US › Healthcare

Apollomics Inc. Class A Ordinary Shares (APLM)

US · Healthcare · Biotechnology

$19.00+11.90%

Last close · 2026-11-06

Key statistics

Market cap

$55.4M

Forward P/E

0.0

P/B

8.12

Book value

$-1.49

EPS (TTM)

$-7.57

52-week high

$28.29

52-week low

$12.50

50-day MA

$23.19

200-day MA

$18.95

Beta

1.56

Analyst view

with an average price target of $2.00.

Shareholding

Insiders

56.46%

Institutions

0.42%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.37%
SBI Securities Co Ltd	0.00%
UBS Group AG	0.00%
BlackRock Inc	0.00%
Citigroup Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Apollomics Inc. Class A Ordinary Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.